These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 38841623)

  • 1. Immune-related gene methylation prognostic instrument for stratification and targeted treatment of ovarian cancer patients toward advanced 3PM approach.
    Jia W; Li N; Wang J; Gong X; Ouedraogo SY; Wang Y; Zhao J; Grech G; Chen L; Zhan X
    EPMA J; 2024 Jun; 15(2):375-404. PubMed ID: 38841623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically relevant immune subtypes based on alternative splicing landscape of immune-related genes for lung cancer advanced PPPM approach.
    Li N; Jia W; Wang J; Shao Q; Feng X; Li Z; Sun W; Kang M; Hu D; Xing L; Zhan X
    EPMA J; 2024 Jun; 15(2):345-373. PubMed ID: 38841624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically relevant stratification of lung squamous carcinoma patients based on ubiquitinated proteasome genes for 3P medical approach.
    Yang J; Ouedraogo SY; Wang J; Li Z; Feng X; Ye Z; Zheng S; Li N; Zhan X
    EPMA J; 2024 Mar; 15(1):67-97. PubMed ID: 38463626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative phosphoproteomics reveals molecular pathway network alterations in human early-stage primary hepatic carcinomas: potential for 3P medical approach.
    Zhang Y; Li N; Yang L; Jia W; Li Z; Shao Q; Zhan X
    EPMA J; 2023 Sep; 14(3):477-502. PubMed ID: 37605650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying oxidative stress-related biomarkers in idiopathic pulmonary fibrosis in the context of predictive, preventive, and personalized medicine using integrative omics approaches and machine-learning strategies.
    Yang F; Wendusubilige ; Kong J; Zong Y; Wang M; Jing C; Ma Z; Li W; Cao R; Jing S; Gao J; Li W; Wang J
    EPMA J; 2023 Sep; 14(3):417-442. PubMed ID: 37605652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitroproteomics is instrumental for stratification and targeted treatments of astrocytoma patients: expert recommendations for advanced 3PM approach with improved individual outcomes.
    Jia W; Gong X; Ye Z; Li N; Zhan X
    EPMA J; 2023 Dec; 14(4):673-696. PubMed ID: 38094577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitinomics revealed disease- and stage-specific patterns relevant for the 3PM approach in human sigmoid colon cancers.
    Yang H; Li N; Chen L; Zhou L; Zhou Y; Liu J; Jia W; Chen R; Su J; Yang L; Gong X; Zhan X
    EPMA J; 2023 Sep; 14(3):503-525. PubMed ID: 37605648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial intelligence in ovarian cancer drug resistance advanced 3PM approach: subtype classification and prognostic modeling.
    Zhang C; Yang J; Chen S; Sun L; Li K; Lai G; Peng B; Zhong X; Xie B
    EPMA J; 2024 Sep; 15(3):525-544. PubMed ID: 39239109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework.
    Liu J; Shi Y; Zhang Y
    EPMA J; 2023 Jun; 14(2):275-305. PubMed ID: 37275552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis.
    Zheng P; Li N; Zhan X
    Front Endocrinol (Lausanne); 2022; 13():972341. PubMed ID: 36545327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A gene signature driven by abnormally methylated DEGs was developed for TP53 wild-type ovarian cancer samples by integrative omics analysis of DNA methylation and gene expression data.
    Zhou Z; Jin H; Xu J
    Ann Transl Med; 2023 Jan; 11(1):20. PubMed ID: 36760264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Validation of Immune-Related Gene for Predicting Prognosis and Therapeutic Response in Ovarian Cancer.
    Zhang ZC; Guo JN; Zhang N; Wang ZQ; Lou G; Cui BB; Yang C
    Front Immunol; 2021; 12():763791. PubMed ID: 34880862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes.
    Li N; Zhan X
    EPMA J; 2020 Jun; 11(2):289-309. PubMed ID: 32549918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer.
    Li N; Zhan X
    EPMA J; 2019 Sep; 10(3):273-290. PubMed ID: 31462944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine.
    Bajinka O; Ouedraogo SY; Golubnitschaja O; Li N; Zhan X
    EPMA J; 2024 Jun; 15(2):289-319. PubMed ID: 38841622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of Tumor Microenvironment Identified Prognostic Immune-Related Gene Signature in Ovarian Cancer.
    Li N; Li B; Zhan X
    Front Genet; 2021; 12():616073. PubMed ID: 33679883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-Related Genes' Prognostic, Therapeutic and Diagnostic Value in Ovarian Cancer Immune-Related Gene Biomarker in Ovarian Cancer.
    Ding B; Yan W; Shen S; Meng D; Chen X; Wang S; Shen Y
    Cancer Control; 2023; 30():10732748231168756. PubMed ID: 37078136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Immune-Related Genes for Risk Stratification in Multiple Myeloma Based on Whole Bone Marrow Gene Expression Profiling.
    Wang QS; Shi QQ; Meng Y; Chen MP; Hou J
    Front Genet; 2022; 13():897886. PubMed ID: 35692836
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer.
    Gao Y; Wang X; Li S; Zhang Z; Li X; Lin F
    Med Sci Monit; 2021 May; 27():e930025. PubMed ID: 34003815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.